Are you over 18 and want to see adult content?
More Annotations
A complete backup of whoneedsmaps.com
Are you over 18 and want to see adult content?
A complete backup of moolollybar.com.au
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of fridaymagazine.ae
Are you over 18 and want to see adult content?
A complete backup of rt-fastor-market2.myshopify.com
Are you over 18 and want to see adult content?
A complete backup of testoteka.narod.ru
Are you over 18 and want to see adult content?
A complete backup of odysseyofthemind.com
Are you over 18 and want to see adult content?
Text
BIOTECH
Filecoin (FIL) Price Hits $69.51. Posted by Amy Steele on Jun 1st, 2021. Filecoin (CURRENCY:FIL) traded down 4.1% against the U.S. dollar during the twenty-four hour period ending at 19:00 PM E.T. on June 1st. Filecoin has a total market cap of $5.25 billion and $656.96 million worth of Filecoin was tradedCORPORATE NEWS
Posted by David Stone on Jun 19th, 2017. Lockheed Martin Corp. is nearing the final stages of a deal that is worth over $37 billion to sell 440 F-35 fighter jets to 11 countries including the U.S. said a pair of sources aware of the talks. KOPPERS (NYSE:KOP) ISSUES FY 2021 EARNINGS GUIDANCE Koppers (NYSE:KOP) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided EPS guidance of 4.350-4.600 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.200. The company issued revenue guidance of $1.70 billion-$1.80 billion, compared to the consensus revenue estimate of $1.72 billion.KOP stock traded
BOLT (BOLT) PRICE REACHES $0.0048 BOLT (CURRENCY:BOLT) traded 4.9% lower against the US dollar during the 1-day period ending at 23:00 PM E.T. on June 10th. One BOLT coin can currently be purchased for $0.0048 or 0.00000013 BTC on popular cryptocurrency exchanges. BOLT has a total market capitalization of $4.79 million and $60,817.00 worth of BOLT was traded on exchanges STK (STK) PRICE HITS $0.0036 STK (CURRENCY:STK) traded 4.6% lower against the US dollar during the 24 hour period ending at 8:00 AM Eastern on June 11th. STK has a total market cap of $1.25 million and $335,206.00 worth of STK was traded on exchanges in the last 24 hours. ESBC MARKET CAP HITS $714,155.47 (ESBC) ESBC (CURRENCY:ESBC) traded 30% higher against the US dollar during the 1 day period ending at 19:00 PM ET on June 10th. In the last week, ESBC has traded up 50.2% against the US dollar. One ESBC coin can currently be purchased for about $0.0255 or 0.00000069 BTC on cryptocurrency exchanges. ESBC has a total GOBYTE PRICE HITS $0.0512 (GBX) GoByte (CURRENCY:GBX) traded 16.5% higher against the dollar during the twenty-four hour period ending at 12:00 PM E.T. on June 11th. Over the last seven days, GoByte has traded 5.7% higher against the dollar. GoByte has a market capitalization of $490,546.57 and $674.00 worth of GoByte was traded on exchanges in the last 24 hours. BIGCOMMERCE (NASDAQ:BIGC) ISSUES Q2 2021 EARNINGS … BigCommerce (NASDAQ:BIGC) updated its second quarter 2021 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $46.40 million-46.90 million, compared to the consensus revenue estimate of $45.67 million. A number of research firms have weighed in on BIGC. Guggenheim raised shares of BigCommerce QUANTUMSCAPE (NYSE:QS) TRADING DOWN 9.4% QuantumScape Co. (NYSE:QS)’s stock price traded down 9.4% during trading on Thursday . The stock traded as low as $28.10 and last traded at $28.12. 211,440 shares were traded during mid-day trading, a decline of 99% from the average session volume of 16,114,715 shares. The stock had previously closed at $31.04. QS has been the PHREESIA (NYSE:PHR) ISSUES FY 2022 EARNINGS GUIDANCE Phreesia (NYSE:PHR) updated its FY 2022 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $191 million-194 million, compared to the consensus revenue estimate of $183.58 million. Several brokerages recently commented on PHR. Berenberg Bank assumed coverage on shares of Phreesia in a report THE CERBAT GEMHEADLINESMARKETSM&AANALYSTS’ UPDATESEARNINGSHEALTH &BIOTECH
Filecoin (FIL) Price Hits $69.51. Posted by Amy Steele on Jun 1st, 2021. Filecoin (CURRENCY:FIL) traded down 4.1% against the U.S. dollar during the twenty-four hour period ending at 19:00 PM E.T. on June 1st. Filecoin has a total market cap of $5.25 billion and $656.96 million worth of Filecoin was tradedCORPORATE NEWS
Posted by David Stone on Jun 19th, 2017. Lockheed Martin Corp. is nearing the final stages of a deal that is worth over $37 billion to sell 440 F-35 fighter jets to 11 countries including the U.S. said a pair of sources aware of the talks. KOPPERS (NYSE:KOP) ISSUES FY 2021 EARNINGS GUIDANCE Koppers (NYSE:KOP) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided EPS guidance of 4.350-4.600 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.200. The company issued revenue guidance of $1.70 billion-$1.80 billion, compared to the consensus revenue estimate of $1.72 billion.KOP stock traded
BOLT (BOLT) PRICE REACHES $0.0048 BOLT (CURRENCY:BOLT) traded 4.9% lower against the US dollar during the 1-day period ending at 23:00 PM E.T. on June 10th. One BOLT coin can currently be purchased for $0.0048 or 0.00000013 BTC on popular cryptocurrency exchanges. BOLT has a total market capitalization of $4.79 million and $60,817.00 worth of BOLT was traded on exchanges STK (STK) PRICE HITS $0.0036 STK (CURRENCY:STK) traded 4.6% lower against the US dollar during the 24 hour period ending at 8:00 AM Eastern on June 11th. STK has a total market cap of $1.25 million and $335,206.00 worth of STK was traded on exchanges in the last 24 hours. ESBC MARKET CAP HITS $714,155.47 (ESBC) ESBC (CURRENCY:ESBC) traded 30% higher against the US dollar during the 1 day period ending at 19:00 PM ET on June 10th. In the last week, ESBC has traded up 50.2% against the US dollar. One ESBC coin can currently be purchased for about $0.0255 or 0.00000069 BTC on cryptocurrency exchanges. ESBC has a total GOBYTE PRICE HITS $0.0512 (GBX) GoByte (CURRENCY:GBX) traded 16.5% higher against the dollar during the twenty-four hour period ending at 12:00 PM E.T. on June 11th. Over the last seven days, GoByte has traded 5.7% higher against the dollar. GoByte has a market capitalization of $490,546.57 and $674.00 worth of GoByte was traded on exchanges in the last 24 hours. BIGCOMMERCE (NASDAQ:BIGC) ISSUES Q2 2021 EARNINGS … BigCommerce (NASDAQ:BIGC) updated its second quarter 2021 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $46.40 million-46.90 million, compared to the consensus revenue estimate of $45.67 million. A number of research firms have weighed in on BIGC. Guggenheim raised shares of BigCommerce QUANTUMSCAPE (NYSE:QS) TRADING DOWN 9.4% QuantumScape Co. (NYSE:QS)’s stock price traded down 9.4% during trading on Thursday . The stock traded as low as $28.10 and last traded at $28.12. 211,440 shares were traded during mid-day trading, a decline of 99% from the average session volume of 16,114,715 shares. The stock had previously closed at $31.04. QS has been the PHREESIA (NYSE:PHR) ISSUES FY 2022 EARNINGS GUIDANCE Phreesia (NYSE:PHR) updated its FY 2022 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $191 million-194 million, compared to the consensus revenue estimate of $183.58 million. Several brokerages recently commented on PHR. Berenberg Bank assumed coverage on shares of Phreesia in a report HEADLINES - THE CERBAT GEM GoBuyside Meets The Specialized Needs Of The Investment Management Industry. Posted by Dan Childress on Jun 19th, 2018 . GoBuyside is a talent recruiting firm that specializes in finding talent for investment management companies in the financial services sector ofthe economy.
FINANCE - THE CERBAT GEM Filed Under: Analyst Articles - CA - Finance. National Bank of Canada (TSE:NA) had its price target upped by stock analysts at Scotiabank from C$98.00 to C$104.00 in a report released on Thursday, BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 11.03% from the company’s previous close.CORPORATE NEWS
Posted by David Stone on Jun 19th, 2017. Lockheed Martin Corp. is nearing the final stages of a deal that is worth over $37 billion to sell 440 F-35 fighter jets to 11 countries including the U.S. said a pair of sources aware of the talks. BOLT (BOLT) PRICE REACHES $0.0048 BOLT (CURRENCY:BOLT) traded 4.9% lower against the US dollar during the 1-day period ending at 23:00 PM E.T. on June 10th. One BOLT coin can currently be purchased for $0.0048 or 0.00000013 BTC on popular cryptocurrency exchanges. BOLT has a total market capitalization of $4.79 million and $60,817.00 worth of BOLT was traded on exchanges QUANTUMSCAPE (NYSE:QS) TRADING DOWN 9.4% QuantumScape Co. (NYSE:QS)’s stock price traded down 9.4% during trading on Thursday . The stock traded as low as $28.10 and last traded at $28.12. 211,440 shares were traded during mid-day trading, a decline of 99% from the average session volume of 16,114,715 shares. The stock had previously closed at $31.04. QS has been the PDS BIOTECHNOLOGY CO. (NASDAQ:PDSB) EXPECTED TO ANNOUNCE Equities analysts expect PDS Biotechnology Co. (NASDAQ:PDSB) to report earnings of ($0.21) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for PDS Biotechnology’s earnings. The highest EPS estimate is ($0.17) and the lowest is ($0.24). PDS Biotechnology reported earnings of ($0.19) per share during the same STK (STK) PRICE HITS $0.0036 STK (CURRENCY:STK) traded 4.6% lower against the US dollar during the 24 hour period ending at 8:00 AM Eastern on June 11th. STK has a total market cap of $1.25 million and $335,206.00 worth of STK was traded on exchanges in the last 24 hours. BIGCOMMERCE (NASDAQ:BIGC) ISSUES Q2 2021 EARNINGS … BigCommerce (NASDAQ:BIGC) updated its second quarter 2021 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $46.40 million-46.90 million, compared to the consensus revenue estimate of $45.67 million. A number of research firms have weighed in on BIGC. Guggenheim raised shares of BigCommerce PHREESIA (NYSE:PHR) ISSUES FY 2022 EARNINGS GUIDANCE Phreesia (NYSE:PHR) updated its FY 2022 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $191 million-194 million, compared to the consensus revenue estimate of $183.58 million. Several brokerages recently commented on PHR. Berenberg Bank assumed coverage on shares of Phreesia in a report FOOTBALLCOIN (XFC) PRICE TOPS $0.0107 Footballcoin (CURRENCY:XFC) traded up 4.9% against the U.S. dollar during the 1-day period ending at 7:00 AM ET on June 11th. Over the last seven days, Footballcoin has traded 4.6% higher against the U.S. dollar. Footballcoin has a total market cap of $4.00 million and approximately $284,088.00 worth of Footballcoin was traded onexchanges in
FINANCE - THE CERBAT GEM Filed Under: Analyst Articles - CA - Finance. National Bank of Canada (TSE:NA) had its price target upped by stock analysts at Scotiabank from C$98.00 to C$104.00 in a report released on Thursday, BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 11.03% from the company’s previous close. ANALYZING REKOR SYSTEMS (REKR) AND ITS RIVALS Rekor Systems (NASDAQ: REKR) is one of 43 publicly-traded companies in the “Communications equipment, not elsewhere classified” industry, but how does it compare to its rivals? We will compare Rekor Systems to similar businesses based on the strength of its analyst recommendations, profitability, earnings, institutional ownership, valuation, risk and dividends. Analyst COMPARING SUMMIT WIRELESS TECHNOLOGIES (WISA) & ITS RIVALS Summit Wireless Technologies (NASDAQ: WISA) is one of 151 publicly-traded companies in the “Semiconductors & related devices” industry, but how does it weigh in compared to its competitors? We will compare Summit Wireless Technologies to similar companies based on the strength of its profitability, dividends, risk, institutional ownership, earnings, valuation and analystrecommendations
NERVE FINANCE (NRV) PRICE TOPS $1.25 Nerve Finance (CURRENCY:NRV) traded up 14.2% against the U.S. dollar during the twenty-four hour period ending at 7:00 AM ET on June 10th. One Nerve Finance coin can now be purchased for $1.25 or 0.00003316 BTC on major exchanges. During the last seven days, Nerve Finance has traded 27.5% lower against the U.S. dollar. Nerve MONERO (XMR) PRICE HITS $256.88 Monero (CURRENCY:XMR) traded down 6.5% against the dollar during the 24-hour period ending at 19:00 PM Eastern on June 10th. One Monero coin can now be bought for about $256.88 or 0.00698461 BTC on exchanges. Monero has a market cap of $4.61 billion and approximately $317.56 million worth of Monero was traded on exchanges in KE (BEKE) AND ITS PEERS FINANCIAL ANALYSIS KE (NYSE: BEKE) is one of 19 public companies in the “Real estate agents & managers” industry, but how does it contrast to its peers? We will compare KE to similar companies based on the strength of its earnings, profitability, analyst recommendations, risk, dividends, valuation and institutional ownership. Insider and Institutional Ownership 30.3% of KE PDS BIOTECHNOLOGY CO. (NASDAQ:PDSB) EXPECTED TO ANNOUNCE Equities analysts expect PDS Biotechnology Co. (NASDAQ:PDSB) to report earnings of ($0.21) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for PDS Biotechnology’s earnings. The highest EPS estimate is ($0.17) and the lowest is ($0.24). PDS Biotechnology reported earnings of ($0.19) per share during the same PORCH GROUP (PRCH) VERSUS THE COMPETITION CRITICAL Porch Group (NASDAQ: PRCH) is one of 318 public companies in the “Prepackaged software” industry, but how does it contrast to its competitors? We will compare Porch Group to related businesses based on the strength of its analyst recommendations, institutional ownership, risk, earnings, dividends, profitability and valuation. Institutional & Insider Ownership 56.8% of Porch Group BIOFRONTERA (NASDAQ:BFRA) ISSUES FY 2021 EARNINGS GUIDANCE Biofrontera (NASDAQ:BFRA) updated its FY 2021 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $30.15 million-38.59 million, compared to the consensus revenue estimate of $34.20 million. Biofrontera stock opened at $6.90 on Thursday. The firm has a market cap of $195.68 million, a KERING (OTCMKTS:PPRUY) UPGRADED AT ZACKS INVESTMENT Zacks Investment Research upgraded shares of Kering (OTCMKTS:PPRUY) from a hold rating to a buy rating in a research note released on Thursday morning, Zacks.com reports. They currently have $102.00 price target on the stock. According to Zacks, “Kering is involved in the design, manufacture and distribution of apparel and accessories. It operates through two FINANCE - THE CERBAT GEM Filed Under: Analyst Articles - CA - Finance. National Bank of Canada (TSE:NA) had its price target upped by stock analysts at Scotiabank from C$98.00 to C$104.00 in a report released on Thursday, BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 11.03% from the company’s previous close. ANALYZING REKOR SYSTEMS (REKR) AND ITS RIVALS Rekor Systems (NASDAQ: REKR) is one of 43 publicly-traded companies in the “Communications equipment, not elsewhere classified” industry, but how does it compare to its rivals? We will compare Rekor Systems to similar businesses based on the strength of its analyst recommendations, profitability, earnings, institutional ownership, valuation, risk and dividends. Analyst COMPARING SUMMIT WIRELESS TECHNOLOGIES (WISA) & ITS RIVALS Summit Wireless Technologies (NASDAQ: WISA) is one of 151 publicly-traded companies in the “Semiconductors & related devices” industry, but how does it weigh in compared to its competitors? We will compare Summit Wireless Technologies to similar companies based on the strength of its profitability, dividends, risk, institutional ownership, earnings, valuation and analystrecommendations
NERVE FINANCE (NRV) PRICE TOPS $1.25 Nerve Finance (CURRENCY:NRV) traded up 14.2% against the U.S. dollar during the twenty-four hour period ending at 7:00 AM ET on June 10th. One Nerve Finance coin can now be purchased for $1.25 or 0.00003316 BTC on major exchanges. During the last seven days, Nerve Finance has traded 27.5% lower against the U.S. dollar. Nerve MONERO (XMR) PRICE HITS $256.88 Monero (CURRENCY:XMR) traded down 6.5% against the dollar during the 24-hour period ending at 19:00 PM Eastern on June 10th. One Monero coin can now be bought for about $256.88 or 0.00698461 BTC on exchanges. Monero has a market cap of $4.61 billion and approximately $317.56 million worth of Monero was traded on exchanges in KE (BEKE) AND ITS PEERS FINANCIAL ANALYSIS KE (NYSE: BEKE) is one of 19 public companies in the “Real estate agents & managers” industry, but how does it contrast to its peers? We will compare KE to similar companies based on the strength of its earnings, profitability, analyst recommendations, risk, dividends, valuation and institutional ownership. Insider and Institutional Ownership 30.3% of KE PDS BIOTECHNOLOGY CO. (NASDAQ:PDSB) EXPECTED TO ANNOUNCE Equities analysts expect PDS Biotechnology Co. (NASDAQ:PDSB) to report earnings of ($0.21) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for PDS Biotechnology’s earnings. The highest EPS estimate is ($0.17) and the lowest is ($0.24). PDS Biotechnology reported earnings of ($0.19) per share during the same PORCH GROUP (PRCH) VERSUS THE COMPETITION CRITICAL Porch Group (NASDAQ: PRCH) is one of 318 public companies in the “Prepackaged software” industry, but how does it contrast to its competitors? We will compare Porch Group to related businesses based on the strength of its analyst recommendations, institutional ownership, risk, earnings, dividends, profitability and valuation. Institutional & Insider Ownership 56.8% of Porch Group BIOFRONTERA (NASDAQ:BFRA) ISSUES FY 2021 EARNINGS GUIDANCE Biofrontera (NASDAQ:BFRA) updated its FY 2021 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $30.15 million-38.59 million, compared to the consensus revenue estimate of $34.20 million. Biofrontera stock opened at $6.90 on Thursday. The firm has a market cap of $195.68 million, a KERING (OTCMKTS:PPRUY) UPGRADED AT ZACKS INVESTMENT Zacks Investment Research upgraded shares of Kering (OTCMKTS:PPRUY) from a hold rating to a buy rating in a research note released on Thursday morning, Zacks.com reports. They currently have $102.00 price target on the stock. According to Zacks, “Kering is involved in the design, manufacture and distribution of apparel and accessories. It operates through two MONERO (XMR) PRICE HITS $256.88 Monero (CURRENCY:XMR) traded down 6.5% against the dollar during the 24-hour period ending at 19:00 PM Eastern on June 10th. One Monero coin can now be bought for about $256.88 or 0.00698461 BTC on exchanges. Monero has a market cap of $4.61 billion and approximately $317.56 million worth of Monero was traded on exchanges in KE (BEKE) AND ITS PEERS FINANCIAL ANALYSIS KE (NYSE: BEKE) is one of 19 public companies in the “Real estate agents & managers” industry, but how does it contrast to its peers? We will compare KE to similar companies based on the strength of its earnings, profitability, analyst recommendations, risk, dividends, valuation and institutional ownership. Insider and Institutional Ownership 30.3% of KE BOLT (BOLT) PRICE REACHES $0.0048 BOLT (CURRENCY:BOLT) traded 4.9% lower against the US dollar during the 1-day period ending at 23:00 PM E.T. on June 10th. One BOLT coin can currently be purchased for $0.0048 or 0.00000013 BTC on popular cryptocurrency exchanges. BOLT has a total market capitalization of $4.79 million and $60,817.00 worth of BOLT was traded on exchanges BIOFRONTERA (NASDAQ:BFRA) ISSUES FY 2021 EARNINGS GUIDANCE Biofrontera (NASDAQ:BFRA) updated its FY 2021 earnings guidance on Tuesday. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $30.15 million-38.59 million, compared to the consensus revenue estimate of $34.20 million. Biofrontera stock opened at $6.90 on Thursday. The firm has a market cap of $195.68 million, a VAIL RESORTS (MTN) VERSUS ITS RIVALS FINANCIAL SURVEY Vail Resorts (NYSE: MTN) is one of 24 public companies in the “Miscellaneous amusement & recreation services” industry, but how does it compare to its rivals? We will compare Vail Resorts to related businesses based on the strength of its risk, profitability, earnings, institutional ownership, analyst recommendations, dividends and valuation. Profitability This table compares Vail ESBC MARKET CAP HITS $714,155.47 (ESBC) ESBC (CURRENCY:ESBC) traded 30% higher against the US dollar during the 1 day period ending at 19:00 PM ET on June 10th. In the last week, ESBC has traded up 50.2% against the US dollar. One ESBC coin can currently be purchased for about $0.0255 or 0.00000069 BTC on cryptocurrency exchanges. ESBC has a total ANALYZING MONRO (NASDAQ:MNRO) & DRIVEN BRANDS … Monro (NASDAQ:MNRO) and Driven Brands (NASDAQ:DRVN) are both consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Earnings and Valuation This table compares Monro and Driven Brands’ top-line MERUS (NASDAQ:MRUS) UPGRADED AT CITIGROUP Citigroup upgraded shares of Merus (NASDAQ:MRUS) from a neutral rating to a buy rating in a research note released on Monday, The Fly reports.. MRUS has been the subject of a number of other reports. Royal Bank of Canada boosted their price objective on shares of Merus from $15.00 to $21.00 and gave the stock a sector perform rating in a report on Wednesday, March 17th. COMPUGEN (NASDAQ:CGEN) TRADING DOWN 4.9% Compugen Ltd. (NASDAQ:CGEN) dropped 4.9% during mid-day trading on Tuesday . The stock traded as low as $7.51 and last traded at $7.55. Approximately 52,303 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,283,782 shares. The stock had previously closed at $7.94. CGEN has been the topic KERING (OTCMKTS:PPRUY) UPGRADED AT ZACKS INVESTMENT Zacks Investment Research upgraded shares of Kering (OTCMKTS:PPRUY) from a hold rating to a buy rating in a research note released on Thursday morning, Zacks.com reports. They currently have $102.00 price target on the stock. According to Zacks, “Kering is involved in the design, manufacture and distribution of apparel and accessories. It operates through two THE CERBAT GEMHEADLINESMARKETSM&AANALYSTS’ UPDATESEARNINGSHEALTH &BIOTECH
Filecoin (FIL) Price Hits $69.51. Posted by Amy Steele on Jun 1st, 2021. Filecoin (CURRENCY:FIL) traded down 4.1% against the U.S. dollar during the twenty-four hour period ending at 19:00 PM E.T. on June 1st. Filecoin has a total market cap of $5.25 billion and $656.96 million worth of Filecoin was traded HEADLINES - THE CERBAT GEM GoBuyside Meets The Specialized Needs Of The Investment Management Industry. Posted by Dan Childress on Jun 19th, 2018 . GoBuyside is a talent recruiting firm that specializes in finding talent for investment management companies in the financial services sector ofthe economy.
FINANCE - THE CERBAT GEM Filed Under: Analyst Articles - CA - Finance. National Bank of Canada (TSE:NA) had its price target upped by stock analysts at Scotiabank from C$98.00 to C$104.00 in a report released on Thursday, BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 11.03% from the company’s previous close. REVIEWING IMMUNOCORE (IMCR) AND ITS RIVALS Immunocore (NASDAQ: IMCR) is one of 196 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will compare Immunocore to related businesses based on the strength of its dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings. Analyst Recommendations This TENNANT (NYSE:TNC) SHARES BOUGHT BY RHUMBLINE ADVISERS Rhumbline Advisers boosted its position in shares of Tennant (NYSE:TNC) by 0.4% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 55,127 shares of the industrial products company’s stock after acquiring an additional 205 shares during the quarter. Rhumbline Advisers’ holdings in Tennant were worth $4,404,000 as of its most recent filing with theCORPORATE NEWS
Posted by David Stone on Jun 19th, 2017. Lockheed Martin Corp. is nearing the final stages of a deal that is worth over $37 billion to sell 440 F-35 fighter jets to 11 countries including the U.S. said a pair of sources aware of the talks. CONTACT - THE CERBAT GEM Contact. Our audience is priority one at The Cerbat Gem. Your questions, comments and feedback are always welcome. We can be reached via email at news@thecerbatgem.com. ROKU (NASDAQ:ROKU) RAISED TO “BUY” AT LOOP CAPITAL Roku (NASDAQ:ROKU) was upgraded by equities researchers at Loop Capital from a “hold” rating to a “buy” rating in a research note issued on Thursday, Benzinga reports. The brokerage presently has a $450.00 price target on the stock. Loop Capital’s price objective would suggest a potential upside of 46.09% from the stock’s currentprice. A
LUMINAR TECHNOLOGIES (NASDAQ:LAZR) RELEASES FY 2021 Luminar Technologies (NASDAQ:LAZR) updated its FY 2021 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of – for the period. The company issued revenue guidance of $25 million-$30 million, compared to the consensus revenue estimate of $27.95 million. Several research firms have recently commented on LAZR. Northland Securities raised VISTA OUTDOOR (NYSE:VSTO) ISSUES Q1 2022 EARNINGS GUIDANCE Vista Outdoor (NYSE:VSTO) issued an update on its first quarter 2022 earnings guidance on Thursday morning. The company provided EPS guidance of 0.800-0.900 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.690. The company issued revenue guidance of $600 million-$620 million, compared to the consensus revenue estimate of $527.32 million. NYSE:VSTO THE CERBAT GEMHEADLINESMARKETSM&AANALYSTS’ UPDATESEARNINGSHEALTH &BIOTECH
Filecoin (FIL) Price Hits $69.51. Posted by Amy Steele on Jun 1st, 2021. Filecoin (CURRENCY:FIL) traded down 4.1% against the U.S. dollar during the twenty-four hour period ending at 19:00 PM E.T. on June 1st. Filecoin has a total market cap of $5.25 billion and $656.96 million worth of Filecoin was traded HEADLINES - THE CERBAT GEM GoBuyside Meets The Specialized Needs Of The Investment Management Industry. Posted by Dan Childress on Jun 19th, 2018 . GoBuyside is a talent recruiting firm that specializes in finding talent for investment management companies in the financial services sector ofthe economy.
FINANCE - THE CERBAT GEM Filed Under: Analyst Articles - CA - Finance. National Bank of Canada (TSE:NA) had its price target upped by stock analysts at Scotiabank from C$98.00 to C$104.00 in a report released on Thursday, BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 11.03% from the company’s previous close. REVIEWING IMMUNOCORE (IMCR) AND ITS RIVALS Immunocore (NASDAQ: IMCR) is one of 196 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will compare Immunocore to related businesses based on the strength of its dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings. Analyst Recommendations This TENNANT (NYSE:TNC) SHARES BOUGHT BY RHUMBLINE ADVISERS Rhumbline Advisers boosted its position in shares of Tennant (NYSE:TNC) by 0.4% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 55,127 shares of the industrial products company’s stock after acquiring an additional 205 shares during the quarter. Rhumbline Advisers’ holdings in Tennant were worth $4,404,000 as of its most recent filing with theCORPORATE NEWS
Posted by David Stone on Jun 19th, 2017. Lockheed Martin Corp. is nearing the final stages of a deal that is worth over $37 billion to sell 440 F-35 fighter jets to 11 countries including the U.S. said a pair of sources aware of the talks. CONTACT - THE CERBAT GEM Contact. Our audience is priority one at The Cerbat Gem. Your questions, comments and feedback are always welcome. We can be reached via email at news@thecerbatgem.com. ROKU (NASDAQ:ROKU) RAISED TO “BUY” AT LOOP CAPITAL Roku (NASDAQ:ROKU) was upgraded by equities researchers at Loop Capital from a “hold” rating to a “buy” rating in a research note issued on Thursday, Benzinga reports. The brokerage presently has a $450.00 price target on the stock. Loop Capital’s price objective would suggest a potential upside of 46.09% from the stock’s currentprice. A
LUMINAR TECHNOLOGIES (NASDAQ:LAZR) RELEASES FY 2021 Luminar Technologies (NASDAQ:LAZR) updated its FY 2021 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of – for the period. The company issued revenue guidance of $25 million-$30 million, compared to the consensus revenue estimate of $27.95 million. Several research firms have recently commented on LAZR. Northland Securities raised VISTA OUTDOOR (NYSE:VSTO) ISSUES Q1 2022 EARNINGS GUIDANCE Vista Outdoor (NYSE:VSTO) issued an update on its first quarter 2022 earnings guidance on Thursday morning. The company provided EPS guidance of 0.800-0.900 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.690. The company issued revenue guidance of $600 million-$620 million, compared to the consensus revenue estimate of $527.32 million. NYSE:VSTO FINANCE - THE CERBAT GEM Filed Under: Analyst Articles - CA - Finance. National Bank of Canada (TSE:NA) had its price target upped by stock analysts at Scotiabank from C$98.00 to C$104.00 in a report released on Thursday, BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 11.03% from the company’s previous close. COMPARING BTRS (BTRS) & ITS RIVALS BTRS (NASDAQ: BTRS) is one of 51 public companies in the “Custom computer programming services” industry, but how does it weigh in compared to its peers? We will compare BTRS to similar companies based on the strength of its dividends, earnings, analyst recommendations, risk, profitability, institutional ownership and valuation. Valuation & Earnings This table compares CRITICAL SURVEY: EARGO (EAR) VERSUS ITS RIVALS Eargo (NASDAQ: EAR) is one of 40 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its rivals? We will compare Eargo to related businesses based on the strength of its valuation, institutional ownership, profitability, risk, dividends, analyst recommendations and earnings. Profitability This table compares Eargo and its rivals’ FINANCIAL SURVEY: CONTEXTLOGIC (WISH) & ITS PEERS ContextLogic (NASDAQ: WISH) is one of 37 public companies in the “Catalog & mail-order houses” industry, but how does it contrast to its competitors? We will compare ContextLogic to similar businesses based on the strength of its profitability, institutional ownership, dividends, risk, valuation, analyst recommendations and earnings. Insider & Institutional Ownership 56.0% of ContextLogic COMPARING KE (BEKE) & THE COMPETITION KE (NYSE: BEKE) is one of 19 publicly-traded companies in the “Real estate agents & managers” industry, but how does it contrast to its competitors? We will compare KE to similar businesses based on the strength of its analyst recommendations, risk, valuation, profitability, institutional ownership, dividends and earnings. Earnings & Valuation This table compares KE CONTRASTING DRAFTKINGS (DKNG) AND ITS RIVALS DraftKings (NASDAQ: DKNG) is one of 24 publicly-traded companies in the “Miscellaneous amusement & recreation services” industry, but how does it contrast to its rivals? We will compare DraftKings to related businesses based on the strength of its risk, dividends, earnings, valuation, institutional ownership, analyst recommendations and profitability. Valuation and Earnings This table SAFEMOON (SAFEMOON) TRADING UP 71.5% OVER LAST WEEK SafeMoon (CURRENCY:SAFEMOON) traded down 7.2% against the dollar during the one day period ending at 19:00 PM ET on May 12th. SafeMoon has a market cap of $5.22 billion and approximately $119.83 million worth of SafeMoon was traded on exchanges in the last 24 hours. One SafeMoon coin can currently be purchased for approximately $0.0000 or 0.00000000 BTC on major CRITICAL SURVEY: 17 EDUCATION & TECHNOLOGY GROUP (YQ 17 Education & Technology Group (NYSE: YQ) is one of 68 public companies in the “Educational services” industry, but how does it weigh in compared to its competitors? We will compare 17 Education & Technology Group to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, analyst recommendations, valuation and dividends. COMPARING VIEMED HEALTHCARE (VMD) AND ITS PEERS Viemed Healthcare (NASDAQ: VMD) is one of 27 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare Viemed Healthcare to similar companies based on the strength of its valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Risk and ENOVA INTERNATIONAL (ENVA) & THE COMPETITION CRITICAL Enova International (NYSE: ENVA) is one of 16 public companies in the “Personal credit institutions” industry, but how does it compare to its rivals? We will compare Enova International to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and valuation. Analyst Ratings This is a summary of Get "Buy" and "Sell" Alerts from Top-Rated Analysts Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with Marketbeat's
FREE daily email newsletter.Privacy Policy
* Home
* Privacy
* About
* Contact
* Headlines
* Markets
* M&A
* Analysts’ Updates* Earnings
* Health & Biotech
* Technology
LATEST NEWS
LOGANSPORT FINANCIAL (OTCMKTS:LOGN) RATING INCREASED TO SELL ATVALUENGINE
November 27th, 2020 - By Scott Moore- Comments Off on
Logansport Financial (OTCMKTS:LOGN) Rating Increased to Sell atValuEngine
Filed Under: Analyst Articles - US-
Finance
Logansport Financial (OTCMKTS:LOGN) was upgraded by equities researchers at ValuEngine from a “strong sell” rating to a “sell” rating in a note issued to investors on Wednesday, ValuEngine reports. Shares of OTCMKTS:LOGN opened at $45.00 on Wednesday. The company’s fifty day moving average price is $41.86 and its 200-day moving average price is $36.11. TheContinue Reading
DEUTSCHE BANK AKTIENGESELLSCHAFT LOWERS VIACOMCBS (NASDAQ:VIAC) TOHOLD
November 27th, 2020 - By Teresa Graham- Comments Off on
Deutsche Bank Aktiengesellschaft Lowers ViacomCBS (NASDAQ:VIAC) toHold
Filed Under: Analyst Articles - US-
Finance
Deutsche Bank Aktiengesellschaft cut shares of ViacomCBS (NASDAQ:VIAC) from a buy rating to a hold rating in a report issued on Tuesday morning, Anlyst Ratings reports. Deutsche Bank Aktiengesellschaft currently has $32.00 price objective on the stock, down from their prior price objective of $33.00. Several other brokerages have also recently issued reports on VIAC.Continue Reading
WASHINGTON TRUST BANCORP (NASDAQ:WASH) UPGRADED AT ZACKS INVESTMENTRESEARCH
November 27th, 2020 - By Teresa Graham- Comments Off on
Washington Trust Bancorp (NASDAQ:WASH) Upgraded at Zacks InvestmentResearch
Filed Under: Analyst Articles - US-
Finance
Zacks Investment Research upgraded shares of Washington Trust Bancorp (NASDAQ:WASH) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $44.00 price objective on the financial services provider’s stock. According to Zacks, “Washington Trust Bancorp, Inc. is a publicly-owned, registered bank holding companyContinue Reading
WEIBO (NASDAQ:WB) UPGRADED AT BIDASKCLUB November 27th, 2020 - By Amy Steele - Comments Off on Weibo (NASDAQ:WB) Upgraded at BidaskClub Filed Under: Analyst Articles - US-
Finance
BidaskClub upgraded shares of Weibo (NASDAQ:WB) from a hold rating to a buy rating in a research note issued to investors on Monday, BidAskClub reports. Several other equities analysts also recently commented on WB. Zacks Investment Research downgraded shares of Weibo from a hold rating to a sell rating in a research note on Friday,Continue Reading
CITIGROUP INC. 3% MINIMUM COUPON PRINCIPAL PROTECTED BASED UPON RUSSELL LOWERS WERNER ENTERPRISES (NASDAQ:WERN) TO NEUTRAL November 27th, 2020 - By Jessica Moore- Comments Off on
Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell Lowers Werner Enterprises (NASDAQ:WERN) to Neutral Filed Under: Analyst Articles - US-
Finance
Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell downgraded shares of Werner Enterprises (NASDAQ:WERN) from a buy rating to a neutral rating in a research report report published on Tuesday morning, AnalystRatings.net reports. They currently have $45.00 price target on the transportation company’s stock, down from their previous price target of $52.00. AContinue Reading
VALUENGINE DOWNGRADES HORIZON THERAPEUTICS PUBLIC (NASDAQ:HZNP) TOSELL
November 27th, 2020 - By Jessica Moore- Comments Off on
ValuEngine Downgrades Horizon Therapeutics Public (NASDAQ:HZNP) toSell
Filed Under: Analyst Articles - US-
Finance
Horizon Therapeutics Public (NASDAQ:HZNP) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday, ValuEngine reports. A number of other research analysts also recently commented on the company. BidaskClub downgraded Horizon Therapeutics Public from a “buy” rating to a “hold” rating in a report onContinue Reading
Q4 2021 EARNINGS ESTIMATE FOR HONDA MOTOR CO., LTD. ISSUED BY JEFFERIES FINANCIAL GROUP (NYSE:HMC) November 27th, 2020 - By Jessica Moore - Comments Off on Q4 2021 Earnings Estimate for Honda Motor Co., Ltd. Issued By Jefferies Financial Group (NYSE:HMC) Filed Under: Analyst Articles - Estimates- Finance
Honda Motor Co., Ltd. (NYSE:HMC) – Equities researchers at Jefferies Financial Group boosted their Q4 2021 earnings per share (EPS) estimates for Honda Motor in a report issued on Tuesday, November 24th. Jefferies Financial Group analyst T. Nakanishi now forecasts that the company will post earnings per share of $0.72 for the quarter, up fromContinue Reading
FORTINET (NASDAQ:FTNT) COVERAGE INITIATED BY ANALYSTS AT KEYCORP November 27th, 2020 - By Renee Jackson - Comments Off on Fortinet (NASDAQ:FTNT) Coverage Initiated by Analysts at KeyCorp Filed Under: Analyst Articles - US-
Finance
KeyCorp initiated coverage on shares of Fortinet (NASDAQ:FTNT) in a research report sent to investors on Monday, The Fly reports. The firm issued a sector weight rating on the software maker’s stock. Several other research analysts have also recently weighed in on FTNT. BidaskClub cut shares of Fortinet from a buy rating to a holdContinue Reading
ELLINGTON FINANCIAL (NYSE:EFC) RECEIVES NEW COVERAGE FROM ANALYSTS ATBTIG RESEARCH
November 27th, 2020 - By Doug Wharley - Comments Off on Ellington Financial (NYSE:EFC) Receives New Coverage from Analysts at BTIGResearch
Filed Under: Analyst Articles - US-
Finance
BTIG Research started coverage on shares of Ellington Financial (NYSE:EFC) in a research report sent to investors on Monday, Analyst Ratings Network reports. The firm issued a buy rating and a $16.50 price target on the financial services provider’s stock. Other research analysts also recently issued research reports about the stock. TheStreet raised shares ofContinue Reading
BTIG RESEARCH INITIATES COVERAGE ON ELLINGTON RESIDENTIAL MORTGAGEREIT (NYSE:EARN)
November 27th, 2020 - By Scott Moore - Comments Off on BTIG Research Initiates Coverage on Ellington Residential Mortgage REIT(NYSE:EARN)
Filed Under: Analyst Articles - US-
Finance
BTIG Research assumed coverage on shares of Ellington Residential Mortgage REIT (NYSE:EARN) in a research report sent to investors on Monday morning, The Fly reports. The brokerage issued a buy rating and a $13.25 target price on the real estate investment trust’s stock. A number of other research firms have also recently issued reports onContinue Reading
NEW YORK MORTGAGE TRUST (NASDAQ:NYMT) COVERAGE INITIATED AT BTIGRESEARCH
November 27th, 2020 - By Jessica Moore - Comments Off on New York Mortgage Trust (NASDAQ:NYMT) Coverage Initiated at BTIG Research Filed Under: Analyst Articles - US-
Finance
BTIG Research started coverage on shares of New York Mortgage Trust (NASDAQ:NYMT) in a research note issued to investors on Monday morning, The Fly reports. The brokerage issued a neutral rating on the real estate investment trust’s stock. NYMT has been the topic of a number of other research reports. Credit Suisse Group reissued aContinue Reading
DYNEX CAPITAL (NYSE:DX) NOW COVERED BY ANALYSTS AT BTIG RESEARCH November 27th, 2020 - By Jessica Moore - Comments Off on Dynex Capital (NYSE:DX) Now Covered by Analysts at BTIG Research Filed Under: Analyst Articles - US-
Finance
BTIG Research initiated coverage on shares of Dynex Capital (NYSE:DX) in a report released on Monday morning, AnalystRatings.net reports. The firm issued a buy rating and a $19.00 price objective on the real estate investment trust’s stock. Other equities research analysts have also issued reports about the stock. Zacks Investment Research upgraded shares of DynexContinue Reading
BTIG RESEARCH BEGINS COVERAGE ON TWO HARBORS INVESTMENT (NYSE:TWO) November 27th, 2020 - By Scott Moore - Comments Off on BTIG Research Begins Coverage on Two Harbors Investment (NYSE:TWO) Filed Under: Analyst Articles - US-
Finance
BTIG Research began coverage on shares of Two Harbors Investment (NYSE:TWO) in a research report report published on Monday, AR Network reports. The firm issued a neutral rating on the real estate investment trust’s stock. TWO has been the topic of a number of other research reports. ValuEngine downgraded Two Harbors Investmentfrom a hold
Continue Reading
ARMATA PHARMACEUTICALS (NYSEAMERICAN:ARMP) DOWNGRADED BY ZACKS INVESTMENT RESEARCH TO “SELL” November 27th, 2020 - By Amy Steele - Comments Off on Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Downgraded by Zacks Investment Research to “Sell” Filed Under: Analyst Articles - US-
Finance
Zacks Investment Research lowered shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) from a hold rating to a sell rating in a research report released on Monday morning, Zacks.com reports. According to Zacks, “Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. TheContinue Reading
ZACKS INVESTMENT RESEARCH DOWNGRADES APOLLO ENDOSURGERY (NASDAQ:APEN)TO HOLD
November 27th, 2020 - By Doug Wharley - Comments Off on Zacks Investment Research Downgrades Apollo Endosurgery (NASDAQ:APEN) toHold
Filed Under: Analyst Articles - US-
Finance
Zacks Investment Research lowered shares of Apollo Endosurgery (NASDAQ:APEN) from a buy rating to a hold rating in a report published on Monday morning, Zacks.com reports. According to Zacks, “Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company’s product segment includes ORBERA (R),Continue Reading
INSMED (NASDAQ:INSM) RECEIVES OUTPERFORM RATING FROM EVERCORE ISI November 27th, 2020 - By Scott Moore - Comments Off on Insmed (NASDAQ:INSM) Receives Outperform Rating from Evercore ISI Filed Under: Analyst Articles - US-
Finance
Evercore ISI restated their outperform rating on shares of Insmed (NASDAQ:INSM) in a report released on Monday, The Fly reports. They currently have a $60.00 target price on the biopharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on the company. Zacks Investment Research raised Insmed from a sell ratingContinue Reading
BIOCRYST PHARMACEUTICALS (NASDAQ:BCRX) EARNS OUTPERFORM RATING FROM ANALYSTS AT EVERCORE ISI November 27th, 2020 - By Teresa Graham- Comments Off on
BioCryst Pharmaceuticals (NASDAQ:BCRX) Earns Outperform Rating from Analysts at Evercore ISI Filed Under: Analyst Articles - US-
Finance
Evercore ISI initiated coverage on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) in a research note published on Monday, The Fly reports. The brokerage issued an outperform rating and a $12.00 price objective on the biotechnology company’s stock. Other equities research analysts have also recently issued reports about the stock. JPMorgan Chase & Co. began coverage onContinue Reading
BANK OF AMERICA DOWNGRADES TFI INTERNATIONAL (NYSE:TFII) TO NEUTRAL November 27th, 2020 - By Scott Moore - Comments Off on Bank of America Downgrades TFI International (NYSE:TFII) to Neutral Filed Under: Analyst Articles - US-
Finance
Bank of America lowered shares of TFI International (NYSE:TFII) from a buy rating to a neutral rating in a research report sent to investors on Monday morning, Analyst Ratings Network reports. TFII has been the topic of several other research reports. Royal Bank of Canada increased their price objective on shares of TFI International fromContinue Reading
CYTOKINETICS (NASDAQ:CYTK) PRICE TARGET LOWERED TO $22.00 AT HCWAINWRIGHT
November 27th, 2020 - By Amy Steele- Comments Off on
Cytokinetics (NASDAQ:CYTK) Price Target Lowered to $22.00 at HCWainwright
Filed Under: Analyst Articles - US-
Finance
Cytokinetics (NASDAQ:CYTK) had its price objective decreased by HC Wainwright from $43.00 to $22.00 in a research note released on Monday morning, The Fly reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on the company. Zacks Investment Research raised Cytokinetics fromContinue Reading
THE TORONTO-DOMINION BANK (NYSE:TD) PT RAISED TO $77.00 November 27th, 2020 - By Doug Wharley - Comments Off on The Toronto-Dominion Bank (NYSE:TD) PT Raised to $77.00 Filed Under: Analyst Articles - US-
Finance
The Toronto-Dominion Bank (NYSE:TD) (TSE:TD) had its target price upped by Scotiabank from $68.00 to $77.00 in a research note issued to investors on Monday morning, The Fly reports. Several other equities analysts have also recently commented on TD. Bank of America cut shares of The Toronto-Dominion Bank from a neutral rating to anunderperform
Continue Reading
SCOTIABANK INCREASES ROYAL BANK OF CANADA (NYSE:RY) PRICE TARGET TO$122.00
November 27th, 2020 - By Renee Jackson- Comments Off on
Scotiabank Increases Royal Bank of Canada (NYSE:RY) Price Target to$122.00
Filed Under: Analyst Articles - US-
Finance
Royal Bank of Canada (NYSE:RY) (TSE:RY) had its price target hoisted by Scotiabank from $111.00 to $122.00 in a research report sent to investors on Monday morning, The Fly reports. Several other analysts have also issued reports on RY. Canaccord Genuity increased their price objective on Royal Bank of Canada from $95.50 to $104.50 andContinue Reading
OLIN (NYSE:OLN) GIVEN NEW $27.00 PRICE TARGET AT ALEMBIC GLOBALADVISORS
November 27th, 2020 - By Teresa Graham - Comments Off on Olin (NYSE:OLN) Given New $27.00 Price Target at Alembic Global Advisors Filed Under: Analyst Articles - US-
Finance
Olin (NYSE:OLN) had its price target boosted by Alembic Global Advisors from $22.00 to $27.00 in a research note released on Monday, The Fly reports. Several other research firms also recently weighed in on OLN. Barclays raised their price target on Olin from $12.00 to $13.00 and gave the stock an equal weight rating inContinue Reading
PRECISION BIOSCIENCES (NASDAQ:DTIL) PT RAISED TO $22.00 November 27th, 2020 - By Renee Jackson- Comments Off on
Precision BioSciences (NASDAQ:DTIL) PT Raised to $22.00 Filed Under: Analyst Articles - US-
Finance
Precision BioSciences (NASDAQ:DTIL) had its price target boosted by Stifel Nicolaus from $21.00 to $22.00 in a report published on Monday, The Fly reports. A number of other brokerages have also weighed in on DTIL. Zacks Investment Research lowered shares of Precision BioSciences from a hold rating to a sell rating in a research reportContinue Reading
COWEN (NASDAQ:COWN) PT RAISED TO $35.00 AT PIPER SANDLER November 27th, 2020 - By Amy Steele - Comments Off on Cowen (NASDAQ:COWN) PT Raised to $35.00 at Piper Sandler Filed Under: Analyst Articles - US-
Finance
Cowen (NASDAQ:COWN) had its price target lifted by Piper Sandler from $25.00 to $35.00 in a report published on Monday, The Fly reports. Other analysts have also issued reports about the company. BidaskClub raised Cowen from a buy rating to a strong-buy rating in a research note on Thursday, October 29th. JMP Securities lifted theirContinue Reading
ADVANCED MICRO DEVICES (NASDAQ:AMD) PT RAISED TO $100.00 November 27th, 2020 - By Teresa Graham- Comments Off on
Advanced Micro Devices (NASDAQ:AMD) PT Raised to $100.00 Filed Under: Analyst Articles - US-
Finance
Advanced Micro Devices (NASDAQ:AMD) had its target price increased by Royal Bank of Canada from $92.00 to $100.00 in a report published on Monday morning, The Fly reports. Other analysts have also issued research reports about the stock. Exane BNP Paribas raised shares of Advanced Micro Devices from a neutral rating to an outperform ratingContinue Reading
IBEX (NASDAQ:IBEX) PT RAISED TO $22.00 AT SMITH BARNEY CITIGROUP November 27th, 2020 - By Renee Jackson - Comments Off on IBEX (NASDAQ:IBEX) PT Raised to $22.00 at Smith Barney Citigroup Filed Under: Analyst Articles - US-
Finance
IBEX (NASDAQ:IBEX) had its target price increased by Smith Barney Citigroup from $18.00 to $22.00 in a report published on Monday morning, The Fly reports. A number of other equities analysts have also weighed in on IBEX. Truist assumed coverage on IBEX in a research note on Tuesday, September 1st. They set a buy ratingContinue Reading
CHINDATA GROUP (NYSE:CD) NOW COVERED BY SMITH BARNEY CITIGROUP November 27th, 2020 - By Teresa Graham- Comments Off on
Chindata Group (NYSE:CD) Now Covered by Smith Barney Citigroup Filed Under: Analyst Articles - US-
Finance
Smith Barney Citigroup started coverage on shares of Chindata Group (NYSE:CD) in a report released on Monday, The Fly reports. The firm issued a buy rating and a $20.00 price objective on the stock. A number of other equities research analysts have also commented on CD. Citigroup Inc. 3% Minimum Coupon Principal Protected Based UponContinue Reading
CANTOR FITZGERALD EQUITIES ANALYSTS INCREASE EARNINGS ESTIMATES FOR HALOZYME THERAPEUTICS, INC. (NASDAQ:HALO) November 27th, 2020 - By Amy Steele - Comments Off on Cantor Fitzgerald Equities Analysts Increase Earnings Estimates for Halozyme Therapeutics, Inc. (NASDAQ:HALO) Filed Under: Analyst Articles - Estimates- Finance
Halozyme Therapeutics, Inc. (NASDAQ:HALO) – Equities research analysts at Cantor Fitzgerald upped their FY2020 earnings estimates for shares of Halozyme Therapeutics in a research note issued on Tuesday, November 24th. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical company will earn $0.95 per share for the year, up from their prior estimate ofContinue Reading
PLYMOUTH INDUSTRIAL REIT (NYSEAMERICAN:PLYM) STOCK RATING UPGRADED BY ZACKS INVESTMENT RESEARCH November 27th, 2020 - By Amy Steele - Comments Off on Plymouth Industrial REIT (NYSEAMERICAN:PLYM) Stock Rating Upgraded by ZacksInvestment Research
Filed Under: Analyst Articles - US-
Finance
Plymouth Industrial REIT (NYSEAMERICAN:PLYM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Plymouth Industrial REIT, Inc. is a full service, vertically integrated real estate investment company. It focused on the acquisition and managementContinue Reading
EVERCORE ISI REAFFIRMS OUTPERFORM RATING FOR ALTIMMUNE (NYSEARCA:ALT) November 27th, 2020 - By Amy Steele - Comments Off on Evercore ISI Reaffirms Outperform Rating for Altimmune (NYSEARCA:ALT) Filed Under: Analyst Articles - US-
Finance
Evercore ISI reissued their outperform rating on shares of Altimmune (NYSEARCA:ALT) in a research report report published on Tuesday, Benzinga reports. They currently have a $25.00 price target on the stock. ALT has been the subject of a number of other research reports. JMP Securities began coverage on shares of Altimmune in a report onContinue Reading
IMI (OTCMKTS:IMIAY) LIFTED TO “OVERWEIGHT” AT JPMORGAN CHASE & CO. November 27th, 2020 - By Scott Moore - Comments Off on IMI (OTCMKTS:IMIAY) Lifted to “Overweight” at JPMorgan Chase & Co. Filed Under: Analyst Articles - US-
Finance
JPMorgan Chase & Co. upgraded shares of IMI (OTCMKTS:IMIAY) from a neutral rating to an overweight rating in a research report released on Tuesday morning, The Fly reports. IMIAY has been the topic of a number of other reports. UBS Group reissued a neutral rating on shares of IMI in a research report on Thursday,Continue Reading
IBI GROUP’S (IBIBF) BUY RATING REITERATED AT ACUMEN CAPITAL November 27th, 2020 - By Doug Wharley - Comments Off on IBI Group’s (IBIBF) Buy Rating Reiterated at Acumen Capital Filed Under: Analyst Articles - US-
Finance
Acumen Capital restated their buy rating on shares of IBI Group (OTCMKTS:IBIBF) in a report published on Tuesday, Analyst Ratings Network reports. The firm currently has a $7.50 price objective on the stock. Several other research analysts also recently commented on IBIBF. Laurentian reissued a buy rating and set a $7.50 priceobjective on shares
Continue Reading
J SAINSBURY (OTCMKTS:JSAIY) STOCK RATING UPGRADED BY ZACKS INVESTMENTRESEARCH
November 27th, 2020 - By Renee Jackson- Comments Off on J
Sainsbury (OTCMKTS:JSAIY) Stock Rating Upgraded by Zacks InvestmentResearch
Filed Under: Analyst Articles - US-
Finance
J Sainsbury (OTCMKTS:JSAIY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage currently has a $13.00 target price on the stock. According to Zacks, “J Sainsbury plc is a leading UK food retailer with interests infinancial
Continue Reading
VALUENGINE UPGRADES KNOW LABS (OTCMKTS:KNWN) TO “BUY” November 27th, 2020 - By Doug Wharley- Comments Off on
ValuEngine Upgrades Know Labs (OTCMKTS:KNWN) to “Buy” Filed Under: Analyst Articles - US-
Finance
ValuEngine upgraded shares of Know Labs (OTCMKTS:KNWN) from a hold rating to a buy rating in a report issued on Monday morning, ValuEngine reports. Shares of KNWN opened at $1.48 on Monday. The company has a 50-day simple moving average of $2.13 and a 200-day simple moving average of $2.18. Know Labs has a 52-weekContinue Reading
LUNDIN ENERGY (OTCMKTS:LNDNF) UPGRADED TO “NEUTRAL” AT UBS GROUP November 27th, 2020 - By Amy Steele - Comments Off on Lundin Energy (OTCMKTS:LNDNF) Upgraded to “Neutral” at UBS Group Filed Under: Analyst Articles - US-
Finance
UBS Group upgraded shares of Lundin Energy (OTCMKTS:LNDNF) from a sell rating to a neutral rating in a research report report published on Tuesday morning, The Fly reports. A number of other equities analysts have also recently issued reports on LNDNF. Berenberg Bank reaffirmed a buy rating on shares of Lundin Energy in a reportContinue Reading
MEGGITT (OTCMKTS:MEGGF) RAISED TO OVERWEIGHT AT BARCLAYS November 27th, 2020 - By Doug Wharley - Comments Off on Meggitt (OTCMKTS:MEGGF) Raised to Overweight at Barclays Filed Under: Analyst Articles - US-
Finance
Barclays upgraded shares of Meggitt (OTCMKTS:MEGGF) from an underweight rating to an overweight rating in a report released on Tuesday morning, The Fly reports. Other equities analysts have also recently issued research reports about the company. Berenberg Bank raised Meggitt from a hold rating to a buy rating in a report on Tuesday, November 17th.Continue Reading
MARUBENI (OTCMKTS:MARUY) DOWNGRADED BY ZACKS INVESTMENT RESEARCH November 27th, 2020 - By Doug Wharley - Comments Off on Marubeni (OTCMKTS:MARUY) Downgraded by Zacks Investment Research Filed Under: Analyst Articles - US-
Finance
Zacks Investment Research cut shares of Marubeni (OTCMKTS:MARUY) from a buy rating to a hold rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Marubeni Corporation purchases, distributes, and markets various industrial and consumer goods worldwide. It is involved in importing and exporting, as well as transactions in theContinue Reading
MAPFRE’S (MPFRF) UNDERWEIGHT RATING REITERATED AT BARCLAYS November 27th, 2020 - By Renee Jackson- Comments Off on
Mapfre’s (MPFRF) Underweight Rating Reiterated at Barclays Filed Under: Analyst Articles - US-
Finance
Barclays reissued their underweight rating on shares of Mapfre (OTCMKTS:MPFRF) in a report released on Tuesday morning, The Fly reports. Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. cut Mapfre from a neutral rating to an underweight rating in a report on Monday, September 7th.Bank of America
Continue Reading
BARRICK GOLD CO. (ABX.TO) (TSE:ABX) TO POST FY2020 EARNINGS OF $1.51 PER SHARE, RAYMOND JAMES FORECASTS November 27th, 2020 - By Renee Jackson - Comments Off on Barrick Gold Co. (ABX.TO) (TSE:ABX) to Post FY2020 Earnings of $1.51 Per Share, Raymond James Forecasts Filed Under: Analyst Articles - Estimates- Finance
Barrick Gold Co. (ABX.TO) (TSE:ABX) (NYSE:ABX) – Equities researchers at Raymond James reduced their FY2020 earnings estimates for shares of Barrick Gold Co. (ABX.TO) in a research report issued on Monday, November 23rd. Raymond James analyst B. Macarthur now expects that the basic materials company will post earnings per share of $1.51for the year,
Continue Reading
ACCOLADE (NASDAQ:ACCD) UPGRADED TO “HOLD” BY ZACKS INVESTMENTRESEARCH
November 27th, 2020 - By Teresa Graham- Comments Off on
Accolade (NASDAQ:ACCD) Upgraded to “Hold” by Zacks InvestmentResearch
Filed Under: Analyst Articles - US-
Finance
Zacks Investment Research upgraded shares of Accolade (NASDAQ:ACCD) from a sell rating to a hold rating in a research report released on Tuesday, Zacks.com reports. According to Zacks, “Accolade Inc. provides personalized, technology-enabled solutions which help people better understand, navigate and utilize the healthcare system. Accolade Inc. is based in SEATTLE. “ Several other equitiesContinue Reading
ALIGN TECHNOLOGY (NASDAQ:ALGN) PT RAISED TO $520.00 AT SVB LEERINK November 27th, 2020 - By Renee Jackson - Comments Off on Align Technology (NASDAQ:ALGN) PT Raised to $520.00 at SVB Leerink Filed Under: Analyst Articles - US-
Finance
Align Technology (NASDAQ:ALGN) had its price target hoisted by SVB Leerink from $460.00 to $520.00 in a research note published on Tuesday, The Fly reports. They currently have an outperform rating on the medical equipment provider’s stock. Several other analysts also recently weighed in on ALGN. Credit Suisse Group boosted their pricetarget on shares
Continue Reading
AMBARELLA (NASDAQ:AMBA) PRICE TARGET RAISED TO $78.00 November 27th, 2020 - By Jessica Moore- Comments Off on
Ambarella (NASDAQ:AMBA) Price Target Raised to $78.00 Filed Under: Analyst Articles - US-
Finance
Ambarella (NASDAQ:AMBA) had its price objective lifted by Stifel Nicolaus from $66.00 to $78.00 in a research report report published on Tuesday morning, The Fly reports. Stifel Nicolaus currently has a buy rating on the semiconductor company’s stock. A number of other research firms have also weighed in on AMBA. Needham & Company LLClifted
Continue Reading
SVB LEERINK BOOSTS ALNYLAM PHARMACEUTICALS (NASDAQ:ALNY) PRICE TARGETTO $91.00
November 27th, 2020 - By Jessica Moore - Comments Off on SVB Leerink Boosts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to$91.00
Filed Under: Analyst Articles - US-
Finance
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target hoisted by SVB Leerink from $90.00 to $91.00 in a research report report published on Tuesday, AnalystRatings.net reports. SVB Leerink currently has a market perform rating on the biopharmaceutical company’s stock. Several other research firms also recently issued reports on ALNY. HC Wainwright reaffirmed a buy rating onContinue Reading
ALNYLAM PHARMACEUTICALS (NASDAQ:ALNY) PRICE TARGET RAISED TO $91.00 November 27th, 2020 - By Jessica Moore- Comments Off on
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $91.00 Filed Under: Analyst Articles - US-
Finance
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target hoisted by SVB Leerink from $90.00 to $91.00 in a research report report published on Tuesday, AnalystRatings.net reports. SVB Leerink currently has a market perform rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently commented on the company. BidaskClub raised AlnylamPharmaceuticals
Continue Reading
AMS (OTCMKTS:AMSSY) EARNS “OVERWEIGHT” RATING FROM JPMORGAN CHASE& CO.
November 27th, 2020 - By Scott Moore - Comments Off on AMS (OTCMKTS:AMSSY) Earns “Overweight” Rating from JPMorgan Chase &Co.
Filed Under: Analyst Articles - US-
Finance
JPMorgan Chase & Co. reaffirmed their overweight rating on shares of AMS (OTCMKTS:AMSSY) in a research report released on Tuesday, The Fly reports. Several other research analysts have also recently weighed in on AMSSY. Credit Suisse Group restated an outperform rating on shares of AMS in a research report on Tuesday, October 6th. Deutsche BankContinue Reading
BORALEX (OTCMKTS:BRLXF) PRICE TARGET RAISED TO $46.25 AT SCOTIABANK November 27th, 2020 - By Renee Jackson - Comments Off on Boralex (OTCMKTS:BRLXF) Price Target Raised to $46.25 at Scotiabank Filed Under: Analyst Articles - US-
Finance
Boralex (OTCMKTS:BRLXF) had its price objective lifted by Scotiabank from $44.50 to $46.25 in a research report released on Monday morning, The Fly reports. The firm currently has an outperform rating on the stock. Other equities analysts also recently issued reports about the company. Raymond James increased their target price on Boralex from$40.00 to
Continue Reading
DBS GROUP (OTCMKTS:DBSDY) RAISED TO “BUY” AT ZACKS INVESTMENTRESEARCH
November 27th, 2020 - By Scott Moore - Comments Off on DBS Group (OTCMKTS:DBSDY) Raised to “Buy” at Zacks Investment Research Filed Under: Analyst Articles - US-
Finance
Zacks Investment Research upgraded shares of DBS Group (OTCMKTS:DBSDY) from a hold rating to a buy rating in a research report report published on Monday morning, Zacks.com reports. Zacks Investment Research currently has $82.00 price target on the financial services provider’s stock. According to Zacks, “DBS Group Holdings Ltd is the holding company of DBSContinue Reading
DEUTSCHE BÖRSE (OTCMKTS:DBOEY) LIFTED TO BUY AT ODDO BHF November 27th, 2020 - By Renee Jackson - Comments Off on Deutsche Börse (OTCMKTS:DBOEY) Lifted to Buy at Oddo Bhf Filed Under: Analyst Articles - US-
Finance
Oddo Bhf upgraded shares of Deutsche Börse (OTCMKTS:DBOEY) from a neutral rating to a buy rating in a report released on Tuesday, The Fly reports. Other research analysts also recently issued reports about the company. Morgan Stanley reissued an equal weight rating on shares of Deutsche Börse in a research note on Wednesday, October14th.
Continue Reading
MORGAN STANLEY LOWERS DANSKE BANK A/S (OTCMKTS:DNKEY) TO UNDERWEIGHT November 27th, 2020 - By Amy Steele - Comments Off on Morgan Stanley Lowers Danske Bank A/S (OTCMKTS:DNKEY) to Underweight Filed Under: Analyst Articles - US-
Finance
Morgan Stanley cut shares of Danske Bank A/S (OTCMKTS:DNKEY) from an equal weight rating to an underweight rating in a research note published on Tuesday morning, The Fly reports. Shares of OTCMKTS:DNKEY opened at $8.43 on Tuesday. The business has a 50-day moving average price of $7.43 and a 200 day moving average price ofContinue Reading
BARCLAYS REAFFIRMS “OVERWEIGHT” RATING FOR AIRBUS (OTCMKTS:EADSY) November 27th, 2020 - By Doug Wharley - Comments Off on Barclays Reaffirms “Overweight” Rating for Airbus (OTCMKTS:EADSY) Filed Under: Analyst Articles - US-
Finance
Barclays reaffirmed their overweight rating on shares of Airbus (OTCMKTS:EADSY) in a report published on Tuesday, The Fly reports. A number of other research firms have also issued reports on EADSY. Nord/LB raised Airbus from a sell rating to a hold rating in a report on Wednesday, November 4th. AlphaValue raised Airbus to a reduceContinue Reading
Older Entries
*
*
*
*
FREE EMAIL NEWSLETTER Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:*
*
The Cerbat Gem Investing News and Analysis 2012-2018. All rightsreserved.
Privacy Policy | About Us | Contact UsDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0